PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist
Visit https://www.peervoice.com/ATJ860 to view the entire programme with slides. After completing “Best Practices for MET Mutation Testing in NSCLC: The Role of the Oncologist and the Pathologist”, participants will be able to: Discuss the rationale for MET biomarker testing in patients with non–small-cell lung cancer (NSCLC); Describe current testing modalities for patients with NSCLC and recent advances in identifying novel mutations; and Apply MET biomarker testing as standard of care for patients with NSCLC.